Signal Management

Signal Management

Signal Management

Signal Management

Detect, Assess, and Anticipate Safety Signals for Your Healthcare Products

In an increasingly demanding regulatory environment, early detection and assessment of safety signals have become critical challenges for pharmaceutical companies, biotech firms, and Marketing Authorization Holders (MAHs).

Signal Management lies at the core of the pharmacovigilance system and plays a key role in:

– continuous benefit-risk monitoring

– identification of emerging risks

– patient protection

– compliance with health authority requirements (EMA, ANSM)

European authorities require MAHs to maintain proactive surveillance of safety data in order to ensure continuous evaluation of medicinal products throughout their lifecycle.

Atessia Vigilances supports Life Sciences organizations in the implementation and oversight of robust, compliant, and inspection-ready Signal Management systems.

Our objective: To strengthen your safety surveillance activities, secure your regulatory obligations, and support risk management decision-making.

Identify Emerging Risks at an Early Stage

Signal detection relies on the continuous analysis of pharmacovigilance data originating from multiple sources.

Atessia Vigilances implements proactive surveillance activities enabling:

  • identification of potential safety signals
  • analysis of safety trends
  • review of data originating from:
    • ICSRs
    • scientific literature
    • health authorities
    • pharmacovigilance databases
  • monitoring of important medical events


A structured approach designed to anticipate risks and strengthen patient safety.
Secure Your Medical and Regulatory Evaluations

Signal assessment requires rigorous scientific analysis to determine the potential impact on the product benefit-risk profile.

Our experts support:

  • medical validation of safety signals
  • analysis of clinical and post-marketing data
  • assessment of causality and frequency
  • identification of risk factors
  • evaluation of regulatory impact


Robust and well-documented evaluations designed to support safety-related decision-making.
Strengthen Your Product Safety Surveillance Strategy

Signal Management directly contributes to the continuous evaluation of the benefit-risk balance of medicinal products and healthcare products.

Atessia Vigilances supports organizations with:

  • periodic review of safety data
  • integration of signals into PSURs/PBRERs
  • updates of Risk Management Plans (RMPs)
  • definition of risk minimization measures
  • coordination with medical and regulatory teams


An integrated approach designed to sustainably secure your products and regulatory obligations.
Signal Detection & Safety Data Review

Optimize the Use of Your Pharmacovigilance Data

The quality of Signal Management activities depends on the reliability and effective use of available safety data.

Our teams support:

  • analysis of pharmacovigilance databases
  • review of EudraVigilance data
  • identification of trends and clusters
  • monitoring of international safety data
  • qualitative and quantitative signal assessment


Optimized use of safety data designed to improve risk detection and support your pharmacovigilance activities.
Regulatory Compliance & Inspection Readiness

Meet EMA and ANSM Expectations

Signal Management activities are closely reviewed during pharmacovigilance inspections.

Atessia Vigilances supports clients with:

  • implementation and remediation of Signal Management processes
  • drafting and review of SOPs
  • documentation of assessments and safety decisions
  • preparation for EMA and ANSM inspections
  • audits and gap assessments


Robust, traceable, and inspection-ready processes designed to reduce regulatory risk.
Processes Designed to Ensure Traceability and Consistency

Our Signal Management activities are integrated within a quality system compliant with Good Pharmacovigilance Practices (GVP).

We ensure:

  • documented methodologies
  • full traceability of analyses
  • scientifically justified assessments
  • workflows compliant with regulatory requirements
  • auditable and reproducible processes


A quality governance framework designed to secure your safety surveillance activities sustainably.

Why Choose Atessia Vigilances ?

Experienced consultants specialized in signal detection, safety analysis, and benefit-risk management.

Compliance with EMA, ANSM, and Good Pharmacovigilance Practices expectations.

Signal Management, regulatory reporting, and PV governance coordinated within the same organization.

Processes designed to support audits and inspections by health authorities.

Targeted support, outsourcing, or strategic consulting depending on your operational needs.

What You Gain by Working with Us

– Early detection of safety signals
– Strengthened benefit-risk surveillance
– Reduced regulatory risk
– Compliance with EMA and ANSM requirements
– Enhanced preparedness for pharmacovigilance inspections

Looking for an Expert Partner in Signal Management?

Atessia Vigilances supports pharmaceutical companies, biotech firms, and Life Sciences organizations in the detection, assessment, and management of safety signals in order to strengthen regulatory compliance and healthcare product safety.

Contact us